"Lysophospholipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal.
Descriptor ID |
D008246
|
MeSH Number(s) |
D10.570.755.375.760.550
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lysophospholipids".
Below are MeSH descriptors whose meaning is more specific than "Lysophospholipids".
This graph shows the total number of publications written about "Lysophospholipids" by people in this website by year, and whether "Lysophospholipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
2017 | 8 | 1 | 9 |
2018 | 7 | 3 | 10 |
2019 | 3 | 0 | 3 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lysophospholipids" by people in Profiles.
-
Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Int J Infect Dis. 2021 Jun; 107:232-233.
-
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis. Drugs. 2021 Jun; 81(9):985-1002.
-
The Anti-Infectious Role of Sphingosine in Microbial Diseases. Cells. 2021 05 04; 10(5).
-
The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections. EMBO Mol Med. 2021 01 11; 13(1):e13533.
-
Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med. 2021 01 11; 13(1):e13424.
-
Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses. Biochimie. 2020 Dec; 179:247-256.
-
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19. Int J Mol Sci. 2020 Sep 29; 21(19).
-
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Int J Mol Sci. 2020 Sep 15; 21(18).
-
The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway. Biochimie. 2020 Dec; 179:237-246.
-
Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy? Front Immunol. 2020; 11:1102.